Search - tctmd.com

Displaying 1 - 20 of 146

Sort: Relevancy | Date

Presentation AHA 2017

Insights from the FOURIER Trial

Presenter: Marc P. Bonaca

November 15, 2017

Presentation AHA 2017

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

Presenter: Akihiko Nogami

November 13, 2017

Presentation Cardiovascular Interventions 2017

How Me The Data: Key Clinical Trials of 2017

Presenter: Curtiss T. Stinis

November 09, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

Presentation TCT 2017

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

Presenter: Saibal Kar

November 02, 2017

Presentation TCT 2017

PFO Closure for Hypoxemia: Who Responds and Who Does Not? Designing a Trial to Prove the Concept

Presenter: Mark Reisman, Brian K. Whisenant, Joseph Kay

November 01, 2017

Presentation TCT 2017

PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial?

Presenter: Mark Reisman, Brian K. Whisenant, Robert J. Sommer

November 01, 2017

Presentation TCT 2017

Commentary I Insights From the 3M Trial

Presenter: David A. Wood

November 01, 2017

Presentation TCT 2017

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Presenter: Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

Presenter: Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Critique and Unanswered Questions

Presenter: David J. Moliterno, Vinod H. Thourani, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

Presenter: Deepak L. Bhatt, C. Michael Gibson

November 01, 2017

Presentation TCT 2017

RESOLVE/SAVORY: Topline Findings and Practice Implications

Presenter: David J. Moliterno, Vinod H. Thourani, Lars Sondergaard

November 01, 2017

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Presentation TCT 2017

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Presenter: Sahil A. Parikh, Thomas Zeller, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Presenter: David J. Maron, Alan C. Yeung, Michael E. Farkouh

November 01, 2017

Presentation TCT 2017

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Presenter: William A. Gray, Thomas Zeller

November 01, 2017

Presentation TCT 2017

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Presenter: William A. Gray, Thomas Zeller, Mitchell Weinberg

November 01, 2017

Advertisement

Insights from the FOURIER Trial

Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial

How Me The Data: Key Clinical Trials of 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

PFO Closure for Hypoxemia: Who Responds and Who Does Not? Designing a Trial to Prove the Concept

PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial?

Commentary I Insights From the 3M Trial

Counterpoint Clinical Trial Results are Inconclusive and Systematic Use of Cerebral Protection During TVR is Unwarranted!

Managing AS Patients With Atrial Fibrillation in TAVR Patients Pharmacotherapy Considerations and LAAC Possibilities (WATCH-TAVR Trial)

RESOLVE/SAVORY: Critique and Unanswered Questions

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation - How to Incorporate the Results in Clinical Practice

RESOLVE/SAVORY: Topline Findings and Practice Implications

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

TAVR in Moderate Aortic Stenosis + Heart Failure: Updates From the UNLOAD Trial

DCB Versus DES for SFA Disease: Data Review and Future Clinical Trials

Current State-of-the-Art Diabetes Medical Management and Novel Therapies in Clinical Trials

Impact of DCB Technique on Long-term Vessel Patency: Can Clinical Outcomes Be Optimized?

Long-term Data With Lower-Dose DCB Technologies (LEVANT, ILLUMINATE, RANGER)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content